跳到正文
cccskills
免费在 GitHub 公开

ata-surgery-day-gc-adjustment

Recommends adjusting glucocorticoid doses on the day of surgery based on illness severity and magnitude of surgical stress. Triggers when managing a patient requiring surgery needing perioperative glucocorticoid management, such as "patient on HC for central AI undergoing major abdominal surgery" or "patient with hypopituitarism scheduled for minor procedure".

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL
查看安装方法

包含的文件（1）

  • SKILL.md2.6 KB

SKILL.md（原文）

安装前可以查看交给 AI 代理的指令内容。

Adjust glucocorticoid doses day of surgery per illness severity and stressor magnitude

STEP 1 — Gather Information

Collect patient's current daily hydrocortisone (HC) dose, type and expected duration of surgery, presence of acute illness or comorbidities, baseline adrenal function, and any concurrent medications that affect GC metabolism (e.g., enzyme-inducing AEDs).

STEP 2 — Rule In / Rule Out

Determine if surgical stress is minor/moderate or major. If minor/moderate (e.g., superficial skin procedure, cataract surgery), proceed to Step 3A; if major (e.g., abdominal, thoracic, orthopedic, neurosurgery), proceed to Step 3B.

STEP 3 — Classify or Stratify

3A Minor/Moderate Stress: Suggest 25–75 mg HC per 24 hours (usually given for 1–2 days), adjusted within the range based on illness severity (higher end for sepsis or significant comorbidities).
3B Major Stress: Suggest a 100 mg HC intravenous bolus followed by a continuous intravenous infusion of 200 mg HC per 24 hours (alternatively 50 mg IV every 6 hours).

STEP 4 — Decide

Administer the selected glucocorticoid regimen perioperatively. After 24–48 hours, taper to the patient's usual maintenance dose based on clinical recovery and reassessment of HPA axis function; if stress dosing exceeded 24 hours, consider a gradual taper over an additional day.

Clinical Guardrails / Mimics / Pitfalls

Avoid over-replacement; monitor for hyperglycemia, fluid retention, and cushingoid features. Do not use dexamethasone in pregnancy. Do not abruptly discontinue GCs after stress dosing without a taper. Consider the patient's baseline HC dose when selecting within the 25–75 mg range for minor/moderate stress.

Concrete Clinical Example

A 45‑year‑old woman on HC 15 mg daily for central adrenal insufficiency undergoes elective colectomy (major surgical stress). She receives 100 mg HC IV bolus at induction, then a continuous IV infusion of 200 mg HC over 24 hours. After 24 hours, the infusion is stopped and she resumes her usual 15 mg HC orally in divided doses.

Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问，或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护，适用 Google 的隐私权政策和服务条款。

同一仓库的技能

780g-pump-adjustment

免费

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-acth-stim-test-interpretation

免费

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-adrenal-crisis-treatment

免费

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-ai-education

免费

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-lt4-monitoring

免费

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-cortisol-cutoff-ai-diagnosis

免费

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题